M. Hirata

LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach

R. C. C. de Freitas, V. Silbiger, R. Hirata, 2023, Molecular Biology Reports.

Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability

G. M. Ferreira, J. Borges, R. H. Bortolin, 2024, Pharmacogenetics and genomics.

Methylation status of LDLR, PCSK9 and LDLRAP1 is associated with cardiovascular events in familial hypercholesterolemia.

V. Silbiger, M. Nakazone, J. Borges, 2024, Epigenomics.